Catalent, Inc. to Present at the 29th Annual Piper Jaffray Healthcare Conference
November 14 2017 - 4:15PM
Business Wire
Catalent, Inc. (NYSE:CTLT), the leading global provider of
advanced delivery technologies and development solutions for drugs,
biologics and consumer health products, today announced that
Matthew Walsh, Executive Vice President & Chief Financial
Officer, will present at the 29th Annual Piper Jaffray Healthcare
Conference at 2:00 p.m. EST on Tuesday, November 28, 2017 in New
York City.
A live webcast of the presentation will be accessible through
the Company’s website at http://investor.catalent.com and will be
available for replay following the event.
About Catalent, Inc.
Catalent is the leading global provider of advanced delivery
technologies and development solutions for drugs, biologics and
consumer health products. With over 80 years serving the industry,
Catalent has proven expertise in bringing more customer products to
market faster, enhancing product performance and ensuring reliable
clinical and commercial product supply. Catalent employs over
10,000 people, including over 1,400 scientists, at more than 30
facilities across 5 continents and in fiscal 2017 generated more
than $2 billion in annual revenue. Catalent is headquartered in
Somerset, N.J. For more information visit www.catalent.com.
More products. Better treatments. Reliably supplied.™
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171114006638/en/
Investor:Catalent, Inc.Thomas Castellano, (732)
537-6325investors@catalent.com
Catalent (NYSE:CTLT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
From Sep 2023 to Sep 2024